Appeals court weighs disputed meeting minutes, referral commissions in Co Diagnostics v. Hukui

SALT LAKE CITY — The Utah Court of Appeals on Tuesday heard argument in a commercial dispute, Co Diagnostics v. Hukui, over whether meeting minutes and surrounding communications created triable issues about a promised commission, unjust enrichment and intentional interference with business relations.

The case was presented to the three-judge panel by John Van Levensals for Hukui, who argued the March 2020 conference-call minutes and related material created disputed facts for a jury about an agreed method to calculate commissions. "There is a discussion about the delta between the wholesale price and the distributor price, which we know, is a dollar," Van Levensals told the court, arguing a reasonable jury could find that the $1 difference reflected an agreed commission and thus supported contract or unjust-enrichment relief.

Mark Morris, arguing for Co Diagnostics, urged affirmance of the trial court’s summary-judgment ruling and characterized Hukui’s claim as a request for "money for nothing," saying the record shows, at best, an open matter to "further discuss" pricing rather than a binding promise. Morris told the panel the meeting minutes reflected an agreement to revisit pricing and did not establish a finalized commission formula that would survive summary judgment.

Why it matters: The dispute centers on whether the March 2020 minutes and subsequent conduct created an enforceable agreement (or, alternativley, a promissory estoppel/unjust enrichment basis) and whether Co Diagnostics used improper means in dealing with a third-party sales force (Intelligent Solutions). The parties also disputed the correct measure of damages if Hukui prevails: unpaid commission versus Co Diagnostics’ profits.

Key factual and legal points discussed

- Contract and price/method: The bench asked whether survival of a breach claim required agreement either on an agreed price or on a method for calculating price. Van Levensals acknowledged Utah law allows oral contracts without an exact price so long as a method exists; he pointed to minutes showing distributor price language and a purported $1 delta as the method Hukui says supports damages.

- Meeting minutes and reasonable inferences: Co Diagnostics argued the minutes represent an agreement to discuss pricing later and do not demonstrate a binding deal. Counsel for Hukui said the minutes and other record evidence (including admissions for purposes of summary judgment) permit a jury to infer Hukui’s $1-per-kit commission or, alternatively, to calculate benefit for an unjust-enrichment claim.

- Unjust enrichment and measure of benefit: Hukui pressed that Co Diagnostics received a substantial benefit from sales linked to introductions through Intelligent Solutions and that a jury could assess benefit based on known per-unit profit testimony in the record. Co Diagnostics responded that the record lacks reliable evidence of the benefit and said profits per unit and related costs were not adequately proved for a jury to quantify unjust enrichment.

- Intentional interference with economic relations: Hukui alleged Co Diagnostics induced Intelligent Solutions to breach an agreement and argued Codex representatives misrepresented regulatory or internal-policy constraints to effect the change. Co Diagnostics said Intelligent Solutions made an independent business decision and that actionable "improper means" requiring independently tortious conduct was not shown.

Quantities and financial context cited in argument

- Distributor price / per-kit figures: Counsel referred repeatedly to a distributor price of $6 per test kit and to a wholesale or other price figure of $7 per kit in the meeting minutes; Hukui argued the $1 difference was the commission it was owed. Those figures were presented as the parties’ understanding in summary-judgment filings, not as a judicial finding.

- Alleged sales and profits: Counsel for Hukui said Co Diagnostics sold roughly $2.3 million in kits tied to the contested relationship and that Co Diagnostics’ witness testimony suggested roughly $4.50 profit per kit on certain sales, which Hukui said supported a claim of substantial benefit if proven to a jury.

What the court did not decide

Judges pressed both sides on what specific record citations would show the parties’ intent and on whether the meeting minutes were an enforceable contract or merely an agreement to agree. The panel asked detailed questions about what evidence of benefit and per-unit profit exists in the record; both sides acknowledged some evidentiary holes and urged that disputed facts be reserved for trial (Hukui) versus resolved as a matter of law (Co Diagnostics).

Ending

The court took the case under advisement after argument and told counsel it would issue a decision as soon as feasible.